DK0983765T3 - Forebyggende midler eller lægemidler mod sygdomme i forbindelse med vaskulær funktionel anomali i relation til insulinresistens - Google Patents

Forebyggende midler eller lægemidler mod sygdomme i forbindelse med vaskulær funktionel anomali i relation til insulinresistens

Info

Publication number
DK0983765T3
DK0983765T3 DK99906501T DK99906501T DK0983765T3 DK 0983765 T3 DK0983765 T3 DK 0983765T3 DK 99906501 T DK99906501 T DK 99906501T DK 99906501 T DK99906501 T DK 99906501T DK 0983765 T3 DK0983765 T3 DK 0983765T3
Authority
DK
Denmark
Prior art keywords
insulin resistance
preventives
drugs
relation
diseases related
Prior art date
Application number
DK99906501T
Other languages
Danish (da)
English (en)
Inventor
Atsunori Kashiwagi
Kazuya Shinozaki
Yoshihiko Nishio
Tomio Okamura
Noboru Toda
Ryuichi Kikkawa
Original Assignee
Daiichi Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Asubio Pharma Co Ltd filed Critical Daiichi Asubio Pharma Co Ltd
Application granted granted Critical
Publication of DK0983765T3 publication Critical patent/DK0983765T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99906501T 1998-02-27 1999-02-26 Forebyggende midler eller lægemidler mod sygdomme i forbindelse med vaskulær funktionel anomali i relation til insulinresistens DK0983765T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04772098A JP4306825B2 (ja) 1998-02-27 1998-02-27 インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤

Publications (1)

Publication Number Publication Date
DK0983765T3 true DK0983765T3 (da) 2007-01-02

Family

ID=12783164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99906501T DK0983765T3 (da) 1998-02-27 1999-02-26 Forebyggende midler eller lægemidler mod sygdomme i forbindelse med vaskulær funktionel anomali i relation til insulinresistens

Country Status (9)

Country Link
US (1) US6410535B1 (de)
EP (1) EP0983765B1 (de)
JP (1) JP4306825B2 (de)
AT (1) ATE340575T1 (de)
DE (1) DE69933347T2 (de)
DK (1) DK0983765T3 (de)
ES (1) ES2272052T3 (de)
PT (1) PT983765E (de)
WO (1) WO1999043325A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
EP1708690B1 (de) * 2003-11-17 2016-07-20 BioMarin Pharmaceutical Inc. Behandlung von phenylketonurie mit bh4
CN101132776A (zh) 2004-11-17 2008-02-27 生物马林药物股份有限公司 稳定的四氢生物喋呤片剂制剂
US20100130500A1 (en) * 2004-12-08 2010-05-27 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
TW200719896A (en) * 2005-04-18 2007-06-01 Astrazeneca Ab Combination product
JP2009518415A (ja) * 2005-12-05 2009-05-07 バイオマリン ファーマシューティカル インコーポレイテッド 疾患の処置のための方法および組成物
JP2010515747A (ja) * 2007-01-12 2010-05-13 ビオマリン プハルマセウトイカル インコーポレイテッド テトラヒドロビオプテリンプロドラッグ
WO2008089148A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
HUE058030T2 (hu) 2007-04-11 2022-06-28 Biomarin Pharm Inc Tetrahidrobiopterin emelt fenilalanin szintekkel összefüggõ állapotok kezelésében történõ alkalmazásra
AU2008347005B2 (en) 2008-01-03 2013-10-03 Biomarin Pharmaceutical Inc. Pterin analog for treating BH4 responsive condition
JP5559656B2 (ja) * 2010-10-14 2014-07-23 大日本スクリーン製造株式会社 熱処理装置および熱処理方法
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
AU572792B2 (en) 1982-09-20 1988-05-19 Wellcome Foundation Limited, The 2-amino, 4-oxo-pteridine derivatives
ZA836957B (en) 1982-09-20 1985-04-24 Wellcome Found Neurologically active chemical compounds
JPS61277618A (ja) 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
JPH0656669A (ja) * 1992-06-11 1994-03-01 Asahi Breweries Ltd 活性酸素消去作用を持つプテリン誘導体製剤
ES2177654T3 (es) 1994-08-05 2002-12-16 Suntory Ltd Remedio contra la degeneracion espinocerebelosa.

Also Published As

Publication number Publication date
EP0983765A1 (de) 2000-03-08
ES2272052T3 (es) 2007-04-16
EP0983765A4 (de) 2001-04-04
JPH11246410A (ja) 1999-09-14
JP4306825B2 (ja) 2009-08-05
PT983765E (pt) 2006-12-29
WO1999043325A1 (fr) 1999-09-02
US6410535B1 (en) 2002-06-25
DE69933347T2 (de) 2007-05-03
US20020082261A1 (en) 2002-06-27
ATE340575T1 (de) 2006-10-15
DE69933347D1 (de) 2006-11-09
EP0983765B1 (de) 2006-09-27

Similar Documents

Publication Publication Date Title
EP0908182A4 (de) Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst ist
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
DK1487829T3 (da) Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte
GB8929070D0 (en) Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
EP2407470A3 (de) Makrocyclische Carbonsäuren und Acylsulfonamide als Hemmer der HCV-Replikation
DK0983765T3 (da) Forebyggende midler eller lægemidler mod sygdomme i forbindelse med vaskulær funktionel anomali i relation til insulinresistens
WO2005056524A3 (en) Therapeutic agents useful for treating pain
ATE181553T1 (de) Kondensierte thiazolverbindungen, ihre darstellung und ihre anwendung
IL111036A0 (en) Beta_alanine derivatives, processes for the preparon thereof and pharmaceutical compositions containing the same
EP1147772A4 (de) Medizinische zusammensetzungen zur behandlung der vorhof-fibrillation
WO1998006400A3 (en) Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
IL148196A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
MX9206930A (es) Nuevos compuestos
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
DE69925225D1 (de) Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
WO2000024389A3 (en) Benzoquinoline derivatives useful as antibacterial agents
DE69424677D1 (de) Präparat zur behandlung der drogenabhängigkeit
WO2002081462A8 (en) Aminoflavone compounds, compositions, and methods of use thereof
CA2236078A1 (en) Prophylactic or therapeutic agents for diseases associated with dysfunction of nos
TH52554A (th) สารประกอบ 2,3-ซับสทิทิวเท็ดอินโดล ที่เป็นสารต่อต้านการอักเสบ และเป็นสารบรรเทาความปวด